LEP and Hepatic fibrosis: miR122 was demonstrated to inhibit liver fibrosis and reduced HSC proliferation; however, leptin treatment was able to reduce its expression in HSC both in vitro and in vivo through the hedgehog signaling pathway [135] and by inducing the phosphorylation of FoxO1 via PI3K/Akt signaling pathway [136].